Find a Doctor

Sarah K Tasian, MD

Attending Physician, Division of Oncology

Assistant Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania


1995 National Merit Finalist
1995 University of Notre Dame Early Action Scholar
1995-1999 University of Notre Dame Honors Program
1999 Outstanding Senior Student in Notre Dame Honors Program
1999 Phi Beta Kappa
1999 USA Today Academic All-American
2001-2002 HHMI-NIH Research Scholars Program fellowship
2003 Alpha Omega Alpha
2009 UCSF Pediatric Fellow Teaching Award
2009-2014 National Institutes of Health Loan Repayment Program (NIH-LRP)
2010 American Society of Clinical Oncology Trainee Travel Award
2010 American Society of Hematology Travel Award
2011-2012 American Society of Clinical Oncology Young Investigator Award
2012-2014 Alex’s Lemonade Stand Foundation Young Investigator Award
2013-2014 Canuso Foundation Innovation Award
2013 ALSF Scholar in Developmental Therapeutics


Memberships in professional organizations

2011 – 2014 ADVL1011 Study Committee Member; Children’s Oncology Group
2013 – present Myeloid Diseases Steering Committee Member; Children’s Oncology Group
2013 – present AML New Agents Committee Member; Children’s Oncology Group
2013 – present Ph-like ALL Working Group Member; Children’s Oncology Group
2014 – present AALL1331 Study Committee Member; Children’s Oncology Group

Original Papers

Peer-Reviewed Original Publications

Gill S*, Tasian SK*, Ruella M, Shestova O, Li Y, Porter DL, Carroll M, Danet-Desnoyers G, Scholler J, Grupp SA, June CH, Kalos M. Efficacy against Human Acute Myeloid Leukemia and Myeloablation of Normal Hematopoiesis in a Mouse Model Using Chimeric Antigen Receptor-Modified T Cells. Blood. 2014 Apr 10;123(15):2343-54. Epub 2014 Mar 4. PMID: 24596416 (*co-first authors)

Gandre-Babbe S, Paluru P, Aribeana C, Chou ST, Bresolin S, Lu L, Sullivan SK, Tasian SK, Weng J, Favre H, Choi JK, French DL, Loh ML, Weiss MJ. Patient-Derived Induced Pluripotent Stem Cells Recapitulate Hematopoietic Abnormalities of Juvenile Myelomonocytic Leukemia. Blood. 2013 Jun 13;121(24):4925-9. Epub 2013 Apr 25. PMID: 23620576

Tasian SK, Doral MY, Borowitz MJ, Wood, BL, Chen IM, Harvey RC, Gastier-Foster JG, Willman CL, Hunger SP, Mullighan CG, Loh ML. Aberrant STAT5 and PI3K/mTOR Pathway Signaling Occurs in Human CRLF2-Rearranged B-Precursor Acute Lymphoblastic Leukemia. Blood. 2012 Jul 26;120(4):833-42. Epub 2012 Jun 8. PMID: 22685175

Maude SL, Tasian SK, Vincent T, Hall JW, Sheen C, Roberts KG, Collins JR, Mullighan CG, Hunger SP, Harvey RC, Willman CL, Fridman JS, Loh ML, Grupp SA, Teachey DT. Targeting JAK1/2 and mTOR in Murine Xenograft Models of Ph-like Acute Lymphoblastic Leukemia (ALL). Blood. 2012 Oct 25;120(17):3510-8. Epub 2012 Sep 6. PMID: 22955920

Chen I-M, Harvey RC, Mullighan CG, Gastier-Foster J, Wharton W, Kang H, Borowitz MJ, Camitta BM, Carroll AJ, Devidas M, Pullen J, Payne-Turner D, Tasian SK, Reshmi S, Cottrell CE, Reaman GH, Bowman WP, Carroll WL, Loh ML, Winick NJ, Hunger SP, Willman CL. Outcome modeling with CRLF2, IKZF1, JAK and Minimal Residual Disease in Pediatric Acute Lymphoblastic Leukemia: A Report from the Children’s Oncology Group. Blood. 2012 Apr 12;119(15):3512-22. Epub 2012 Feb 24. PMID: 22368272

Tasian SK, Kim GE, Miniati DN, and DuBois SG. Development of Anaplastic Wilms Tumor and Subsequent Relapse in a Child with Diaphanospondylodysostosis. J Pediatr Hematol Oncol. 34(7): 548-51, 2012. PMID: 22469945

Pulido J, McMahon P, Treat JR, Gunselman J, Tasian GE, Tasian SK. Labial Ecythma Gangrenosum in an Immunocompromised Infant with Leukemia: Heightening Awareness for the Urologist. Urology. 2012 Dec;80(6):1366-8. Epub 2012 Oct 2. PMID: 23040328

Kavcic M, Fisher BT, Li Y, Seif AE, Torp K, Walker DM, Huang YS, Lee GE, Tasian SK, Vujkovic M, Bagatell R, Aplenc R. Induction Mortality and Resource Utilization in Children Treated for Acute Myeloid Leukemia from 1999 to 2010 at 39 Free-Standing Pediatric Hospitals in the United States. Cancer. 2013 May 15;119(10):1916-23. Epub 2013 Feb 21. PMID: 23436301


« Back to Previous Page
  • Print
  • Share

Contact Us